newsfilter
← Latest News
PR Newswire·

Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline

Mentari Therapeutics, Inc. ("Mentari"), a privately-held biotechnology company developing therapies for migraine prevention, today announced a $200...